Press releases
- Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024
- Edwards Lifesciences to Acquire Innovalve
- Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
- Edwards Lifesciences to Sell Critical Care to BD
- Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
- Edwards Lifesciences Reports First Quarter Results
More ▼
Key statistics
As of last trade EDWARDS LIFEDRN (E1WL34:SAO) traded at 120.14, -7.31% below its 52-week high of 129.61, set on Jul 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 120.14 |
---|---|
High | 120.14 |
Low | 120.14 |
Bid | 121.51 |
Offer | 121.92 |
Previous close | 120.14 |
Average volume | 18.14 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 22 2024 19:33 BST.
More ▼